These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 14971874)
21. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. Okada SK; Siegel JN JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760 [No Abstract] [Full Text] [Related]
22. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
23. Late onset of long-lasting fever as a sole complication of treatment with anti-TNFalpha. Tassiopoulos S; Benopoulou O; Mytilineou E; Andreopoulos A; Vaiopoulos G Clin Exp Rheumatol; 2005; 23(1):122-3. PubMed ID: 15789902 [No Abstract] [Full Text] [Related]
24. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Fabre S; Gibert C; Lechiche C; Dereure J; Jorgensen C; Sany J Clin Exp Rheumatol; 2005; 23(6):891-2. PubMed ID: 16396712 [TBL] [Abstract][Full Text] [Related]
25. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698 [No Abstract] [Full Text] [Related]
26. Extraarticular rheumatoid arthritis and drug-induced syndromes: understanding the role of tumor necrosis factor inhibitors. Bruyn GA J Rheumatol; 2004 Jul; 31(7):1461; author reply 1462. PubMed ID: 15229972 [No Abstract] [Full Text] [Related]
27. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933 [TBL] [Abstract][Full Text] [Related]
29. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab]. D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489 [TBL] [Abstract][Full Text] [Related]
30. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus-induced infectious mononucleosis-like syndrome in a rheumatoid arthritis patient treated with methotrexate and infliximab. Shimojima Y; Ishii W; Matsuda M; Nakazawa H; Ikeda S Intern Med; 2010; 49(10):937-40. PubMed ID: 20467180 [TBL] [Abstract][Full Text] [Related]
32. How does infliximab work in rheumatoid arthritis? Maini RN; Feldmann M Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154 [TBL] [Abstract][Full Text] [Related]
33. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. Keating GM; Perry CM BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485 [TBL] [Abstract][Full Text] [Related]
34. Cryptococcal meningitis in a patient treated with infliximab. Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111 [TBL] [Abstract][Full Text] [Related]
35. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Curtis JR; Patkar N; Xie A; Martin C; Allison JJ; Saag M; Shatin D; Saag KG Arthritis Rheum; 2007 Apr; 56(4):1125-33. PubMed ID: 17393394 [TBL] [Abstract][Full Text] [Related]
36. The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports. Metyas S; La D; Arkfeld DG Ann Rheum Dis; 2007 Nov; 66(11):1544-5. PubMed ID: 17934084 [No Abstract] [Full Text] [Related]
37. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863 [TBL] [Abstract][Full Text] [Related]
38. Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. Iannone F; Trotta F; Montecucco C; Giacomelli R; Galeazzi M; Matucci-Cerinic M; Ferri C; Cutolo M; Maria Bambara L; Triolo G; Ferraccioli G; Valentini G; Lapadula G; Ann Rheum Dis; 2007 Feb; 66(2):249-52. PubMed ID: 16837489 [TBL] [Abstract][Full Text] [Related]
39. Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker. Agarwal PK; Gallaghar M; Murphy E; Virdi M Indian J Ophthalmol; 2007; 55(3):230-2. PubMed ID: 17456948 [TBL] [Abstract][Full Text] [Related]
40. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Listing J; Strangfeld A; Kekow J; Schneider M; Kapelle A; Wassenberg S; Zink A Arthritis Rheum; 2008 Mar; 58(3):667-77. PubMed ID: 18311816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]